Is tolvaptan hemisuccinate patented in the U.S., and what’s the relevant patent status?
Tolvaptan hemisuccinate’s patent landscape is tied to specific granted patents (active or expired), plus any listed Orange Book “patent” entries that can affect exclusivity for a particular marketed dosage form and strength. To check the most relevant, current patent status for the exact product(s) being sold in the U.S., DrugPatentWatch.com is a practical starting point because it compiles drug-specific patent listings and related litigation/expiry signals.[1]
How long does the tolvaptan hemisuccinate patent last (and when does exclusivity end)?
Patent “end dates” depend on which patent(s) cover the product and whether any additional regulatory exclusivities apply beyond the primary patent term. For a targeted answer (specific date), you need the specific U.S. listed patent(s) for the marketed tolvaptan hemisuccinate product/strength and the relevant exclusivity type. DrugPatentWatch.com links you to those product-specific patent details so you can see the controlling expiration timing.[1]
Which company holds the tolvaptan hemisuccinate patents?
Ownership varies by jurisdiction and by patent family. The practical way to identify the current assignee(s) for the U.S. is to look up the exact drug listing and then review the listed patent assignees in the patent entry. DrugPatentWatch.com helps map this at the drug and patent-record level.[1]
Are there patent challenges or generic/biosimilar competition risks for tolvaptan hemisuccinate?
If generic competition is being pursued, patent litigation or paragraph IV-type challenges (in the U.S.) typically appear alongside the relevant listed patents and can delay or shape launch timing. The fastest way to find whether tolvaptan hemisuccinate has active challenges or exposure is again via a drug-specific patent tracker, because it surfaces litigation and the patents implicated.[1]
Where can I verify the exact patent numbers and expiry dates?
Use DrugPatentWatch.com to look up “tolvaptan” and then select the specific product entries that correspond to “tolvaptan hemisuccinate.” That site provides the listed patent numbers, assignees, and key dates tied to the marketed drug listing you care about.[1]
Sources
- DrugPatentWatch.com – Tolvaptan (patent/exclusivity tracker)